Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018616 · ClinicalTrials.gov registry record · Phase 2
Improving Compliance With Metformin
A Phase 2 study of Diabetes, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 79
- Enrollment target
- 1
- Study location
NCT00018616: Completed Phase 2 study of Diabetes, sponsored by US Department of Veterans Affairs.
NCT00018616 is a Phase 2 study of Diabetes that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 79 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00018616, a Phase 2 study of Diabetes, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.
Conditions Studied
Interventions
- BEHAVIORAL MEMS caps
Study Locations (1)
Connecticut
- VA Connecticut Health Care System (West Haven) - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 1999-10 |
| Est. Completion | 2005-01 |
| Phase | Phase 2 |
What the finished NCT00018616 record still lists
NCT00018616 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which MEMS caps is the first listed.
NCT00018616 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00018616 about?
NCT00018616 is a clinical study titled "Improving Compliance With Metformin". This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.
What is the current status of trial NCT00018616?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 79 participants. The study started on 1999-10. Estimated completion is 2005-01.
What conditions does trial NCT00018616 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT00018616?
The interventions under investigation include: MEMS caps (BEHAVIORAL).
Who is sponsoring clinical trial NCT00018616?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00018616 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00018616's enrollment target sits among peer trials
79 216th of 338 higher than 123 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
RECRUITING · Phase 2
-
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
ACTIVE NOT RECRUITING · Phase 2
-
Biomarker Guided Therapies in Stage A/B Heart Failure
COMPLETED · Phase 2
-
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial
COMPLETED · Phase 2
-
Effects of Human Leptin Replacement
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia